Tezepelumab in severe asthma: chest computed tomography assessment of airway remodeling and clinical remission
In summary, tezepelumab induced significant benefits in patients with severe asthma in this real-world cohort, improving symptoms, lung function, and radiological outcomes.
Authors
- Nadia Lobello (ORCID: https://orcid.org/0009-0002-8832-479X)
- Claudia Crimi
- Francesco Manti (ORCID: https://orcid.org/0000-0003-2284-7782)
- Alessandro Vatrella (ORCID: https://orcid.org/0000-0001-8265-3037)
- C Battaglia (ORCID: https://orcid.org/0000-0002-5338-2386)
- Giovanna Lucia Piazzetta
- Chiara Lupia
- Giovanni Sireno
- Emanuela Chiarella
- Daniela Pastore
- Alessandro Pullano
- Pier Paolo Arcuri
- Corrado Pelaia
- Girolamo Pelaia
Institutions
- Gachon University (KR)
- University of Salerno (IT)
- Magna Graecia University (IT)
- University of Catania (IT)
- Dulbecco Telethon Institute (IT)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-01-30
- DOI
- https://doi.org/10.3389/fphar.2026.1757754
- Citations
- 1
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 32.84